article thumbnail

Beyond ‘good’ practices

Pharma Manufacturing

Pharma quality regulation has evolved beyond routine CGMP compliance toward a more holistic, proactive approach

article thumbnail

Why should pharma invest in digital products for those living with rare diseases?


Each person living with a rare disease has a unique experience of their condition, but all will have faced similar challenges. They have suffered from an overwhelming diagnosis experience that has left them feeling misunderstood, isolated, and desperate for someone to help them connect symptoms and make sense of the sheer volume of information.